Clinical trial
A Multicenter, Double-blind, Randomized, Placebo-controlled Extension Study Assessing the Efficacy and Long-term Safety of a 2 mg Dose of TH9507, a GHRH Analog, in HIV Subjects With Excess Abdominal Fat Accumulation
NCT00608023 is registered in ClinicalTrials.gov with Theratechnologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Randomized, Placebo-controlled Extension Study Assessing the Efficacy and Long-term Safety of a 2 mg Dose of TH9507, a GHRH Analog, in HIV Subjects With Excess Abdominal Fat Accumulation
- Lead sponsor
- Theratechnologies
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 31, 2007
- Completion date
- October 31, 2008
- Enrollment
- 263 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.